OmniAb, Inc. – NASDAQ:OABI

OmniAb stock price today

$2.02
-1.56
-43.73%
Financial Health
0
1
2
3
4
5
6
7
8
9

OmniAb stock price monthly change

-19.87%
month

OmniAb stock price quarterly change

-19.87%
quarter

OmniAb stock price yearly change

-41.81%
year

OmniAb key metrics

Market Cap
418.70M
Enterprise value
N/A
P/E
-14.74
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
35.79
Price/Book
2.01
PEG ratio
0.27
EPS
-0.64
Revenue
21.04M
EBITDA
-66.81M
Income
-63.48M
Revenue Q/Q
-77.53%
Revenue Y/Y
-68.29%
Profit margin
-147.85%
Oper. margin
-181.56%
Gross margin
0%
EBIT margin
-181.56%
EBITDA margin
-317.49%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

OmniAb stock price history

OmniAb stock forecast

OmniAb financial statements

OmniAb, Inc. (NASDAQ:OABI): Profit margin
Jun 2023 6.94M -14.72M -212.04%
Sep 2023 5.47M -15.73M -287.35%
Dec 2023 4.82M -14.05M -291.44%
Mar 2024 3.80M -18.96M -498.84%
OmniAb, Inc. (NASDAQ:OABI): Analyst Estimates
Dec 2023 4.82M -14.05M -291.44%
Mar 2024 3.80M -18.96M -498.84%
Oct 2025 12.80M -11.41M -89.15%
Dec 2025 18.34M -7.38M -40.27%
  • Analysts Price target

  • Financials & Ratios estimates

OmniAb, Inc. (NASDAQ:OABI): Earnings per share (EPS)
2023-11-09 -0.14 -0.16
2024-03-20 -0.17 -0.14
2024-05-09 -0.17 -0.19
OmniAb, Inc. (NASDAQ:OABI): Debt to assets
Jun 2023 405239000 71.43M 17.63%
Sep 2023 391708000 67.15M 17.15%
Dec 2023 401985000 87.4M 21.74%
Mar 2024 352556000 51.16M 14.51%
OmniAb, Inc. (NASDAQ:OABI): Cash Flow
Jun 2023 -10.02M 7.78M 478K
Sep 2023 -6.19M 6.28M 171K
Dec 2023 -9.12M 4.73M -496K
Mar 2024 -17.03M 19.93M -203K

OmniAb alternative data

OmniAb, Inc. (NASDAQ:OABI): Employee count
Aug 2023 95
Sep 2023 95
Oct 2023 95
Nov 2023 95
Dec 2023 95
Jan 2024 95
Feb 2024 95
Mar 2024 106
Apr 2024 106
May 2024 106
Jun 2024 106
Jul 2024 106

OmniAb other data

40.84% -37.99%
of OABI is owned by hedge funds
34.84M -30.27M
shares is hold by hedge funds

OmniAb, Inc. (NASDAQ:OABI): Insider trades (number of shares)
Period Buy Sel
Mar 2024 225000 0
Apr 2024 0 25757
May 2024 240000 0
Dec 2024 0 45527
Transaction Date Insider Security Shares Price per share Total value Source
Sale
BERKMAN CHARLES S officer: Chief Le.. Common Stock 8,022 $4.13 $33,131
Sale
GUSTAFSON KURT A officer: Executiv.. Common Stock 23,871 $4.13 $98,587
Sale
FOEHR MATTHEW W director, officer.. Common Stock 13,634 $4.13 $56,308
Option
BERKMAN CHARLES S officer: Chief Le.. Common Stock 15,621 N/A N/A
Option
BERKMAN CHARLES S officer: Chief Le.. Restricted Stock Units 15,621 N/A N/A
Option
FOEHR MATTHEW W director, officer.. Common Stock 68,360 $3.75 $256,350
Option
FOEHR MATTHEW W director, officer.. Common Stock 31,074 $3.68 $114,352
Option
FOEHR MATTHEW W director, officer.. Stock Option (right to buy) 68,360 $3.75 $256,350
Option
FOEHR MATTHEW W director, officer.. Stock Option (right to buy) 31,074 $3.68 $114,352
Option
BERTOZZI CAROLYN R director
Common Stock 17,769 N/A N/A
Monday, 16 December 2024
businesswire.com
Tuesday, 12 November 2024
seekingalpha.com
zacks.com
Saturday, 10 August 2024
seekingalpha.com
Tuesday, 6 August 2024
seekingalpha.com
Monday, 3 June 2024
businesswire.com
Monday, 20 May 2024
businesswire.com
Wednesday, 15 May 2024
businesswire.com
Friday, 10 May 2024
seekingalpha.com
Thursday, 9 May 2024
businesswire.com
Wednesday, 1 May 2024
businesswire.com
Monday, 22 April 2024
Business Wire
Wednesday, 20 March 2024
Seeking Alpha
Wednesday, 28 February 2024
Zacks Investment Research
Friday, 15 December 2023
InvestorPlace
Thursday, 26 October 2023
InvestorPlace
Monday, 25 September 2023
Seeking Alpha
Saturday, 12 August 2023
Seeking Alpha
Tuesday, 13 June 2023
InvestorPlace
Thursday, 18 May 2023
InvestorPlace
Tuesday, 16 May 2023
PennyStocks
Wednesday, 26 April 2023
InvestorPlace
Sunday, 2 April 2023
Seeking Alpha
  • What's the price of OmniAb stock today?

    One share of OmniAb stock can currently be purchased for approximately $2.02.

  • When is OmniAb's next earnings date?

    Unfortunately, OmniAb's (OABI) next earnings date is currently unknown.

  • Does OmniAb pay dividends?

    No, OmniAb does not pay dividends.

  • How much money does OmniAb make?

    OmniAb has a market capitalization of 418.70M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 42.17% to 34.16M US dollars. OmniAb made a loss 50.62M US dollars in net income (profit) last year or -$0.19 on an earnings per share basis.

  • What is OmniAb's stock symbol?

    OmniAb, Inc. is traded on the NASDAQ under the ticker symbol "OABI".

  • What is OmniAb's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of OmniAb?

    Shares of OmniAb can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does OmniAb have?

    As Jul 2024, OmniAb employs 106 workers.

  • When OmniAb went public?

    OmniAb, Inc. is publicly traded company for more then 3 years since IPO on 30 Sep 2021.

  • What is OmniAb's official website?

    The official website for OmniAb is omniab.com.

  • Where are OmniAb's headquarters?

    OmniAb is headquartered at 5980 Horton Street, EmeryVille, CA.

  • How can i contact OmniAb?

    OmniAb's mailing address is 5980 Horton Street, EmeryVille, CA and company can be reached via phone at +51 02507800.

OmniAb company profile:

OmniAb, Inc.

omniab.com
Exchange:

NASDAQ

Full time employees:

106

Industry:

Biotechnology

Sector:

Healthcare

OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur that features unique structural attributes of cow antibodies for complex targets. The company was founded in 2012 and is headquartered in Emeryville, California.

5980 Horton Street
EmeryVille, CA 94608

CIK: 0001846253
ISIN: US68218J1034
CUSIP: 68218J103